Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
  1. Home
  2. Stock
  3. VIR
VIR logo

VIR News & Events

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

VIR News

Wall Street Analysts Adjust Ratings

Mar 04 2026Benzinga

Significant Milestones in Biotech Sector This Week

Feb 27 2026NASDAQ.COM

Vir Biotechnology Announces Pricing of Public Offering

Feb 26 2026NASDAQ.COM

Marriott Vacations Reports Strong Q4, Shares Surge

Feb 26 2026Benzinga

Vir Biotechnology Prices Public Offering at $8.50 per Share

Feb 26 2026seekingalpha

Vir Biotechnology Prices Public Offering at $8.50 per Share

Feb 26 2026Businesswire

Vir Biotechnology Prices Public Offering at $8.50 per Share

Feb 26 2026Newsfilter

Vir Biotechnology Plans $200M Public Offering

Feb 24 2026seekingalpha

VIR Events

02/26 06:20
Deal Size Reduced to $150M in Common Stock
The deal size was reduced to $150M in common stock from $200M in common stock. Goldman Sachs, Leerink, Evercore ISI and Barclays acted as joint book running managers for the offering.
02/24 16:40
Major Averages Bounce Back, Investors Focus on AI News
The major averages closed broadly higher in a bounce-back from yesterday's declines, though sentiment remains fragile with tariff worries and AI-related risk aversion still front and center. Investors continue to digest more and more AI news - including AMD's newest GPU partnership with Meta as well as Anthropic's latest partnerships with companies like Intuit and DocuSign - while staying alert for any market-moving news coming out of tonight's State of the Union address.Looking to commodities, gold dipped following yesterday's sharp gains as the "safe haven" asset continues seesawing in value. Oil prices were mostly flat ahead of API crude data set for release this afternoon.Get caught up quickly on the top news and calls moving stocks with these five Top Five lists.1. STOCK NEWS:Home Depotreported, provided its outlook for FY26, and increased its quarterly dividendAMDand Metaannounced anto deploy 6-gigawatts of AMD GPUsBed Bath & Beyondreportedand provided FY26 revenue guidanceIntuitand Anthropic announced aWarner Bros. Discoveryreceived afrom Paramount2. WALL STREET CALLS:Qualcommto Buy at Loop Capital and to Equal Weight at Wells FargoMorgan StanleyBooking, says "just as important in agentic world"Comcastto Underperform at BNP Paribas on fiber headwindsBarclaysGossamer Bioto Underweight from OverweightHims & Hersto Neutral at BTIG after "disappointing" Q4 report3. AROUND THE WEB:Unityis working with an adviser on a potential sale of its China business, Bloomberg reportsOmnicomis planning to eliminate an additional 94 roles in the U.S. starting March 1, which comes following its $13B November acquisition of Interpublic Group and 4,000 related redundancies, Adweek saysIrenic Capital Management, holding roughly a 2% stake in Ralliant, is urging the precision technology company to accelerate stock buybacks, reduce costs, and increase focus on its defense and electronics business, according to sources familiar with the private discussions, Reuters reportsHondahas suspended operations at its facility in Guadalajara, Mexico, while employees at other manufacturers work from home, after a wave of violence was unleashed by the killing of one of the country's most wanted cartel leaders, FT saysJPMorganChase CEO Jamie Dimon said fears of AI are overblown, noting the company will use the technology to its advantage, WSJ reports4. MOVERS:Larimar Therapeuticsadvanced after the FDA grantedto nomlabofuspPayPal (PYPL) rose after Bloomberg reported that Stripe isof all or part of the companyClarivateand Vir Biotechnologyclosed higher afterShoals Technologyfell afterand entering an agreement with ON.energyXometrydeclined afterand appointing a new CEO5. EARNINGS/GUIDANCE:Chewybacked itsPlayboyreported, with CEO Ben Kohn commenting, "Our preliminary fourth quarter results demonstrate the significant progress we have made executing our strategic transformation"NRG Energy, with EPS and revenue beating consensusHarmony Biosciencesand backed its guidance for FY26FISand provided guidance for Q1 and FY26INDEXES:The Dow rose 370.44, or 0.76%, to 49,174.50, the Nasdaq gained 236.41, or 1.04%, to 22,863.68, and the S&P 500 advanced 52.32, or 0.77%, to 6,890.07.
02/24 16:20
Goldman Sachs and Others Act as Book-Running Managers for Offering
Goldman Sachs & Co. LLC, Leerink Partners, Evercore ISI and Barclays are acting as book-running managers for the offering.

VIR Monitor News

Vir Biotechnology Secures $335 Million Deal with Astellas for VIR-5500

Feb 24 2026

VIR Earnings Analysis

No Data

No Data

People Also Watch